What is the current size and annual growth rate of the bioprocess automation market?
The bioprocess automation market size has grown rapidly in recent years. It will grow from $5.67 billion in 2024 to $6.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increased efficiency, cost reduction, risk mitigation, rising demand for remote monitoring and control, and reduced labor dependency.
The bioprocess automation market size is expected to see rapid growth in the next few years. It will grow to $10.27 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to enhanced productivity, regulatory compliance, process optimization, predictive maintenance predictive maintenance, and real-time analytics. Major trends in the forecast period include integration of ai and machine learning, modular bioprocessing, process control strategies for gene therapy, process control strategies for gene therapy, and data analytics and visualization.
Get Your Free Sample of The Global Bioprocess Automation Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14058&type=smp
Which major factors have contributed to the expansion of the bioprocess automation market?
The increasing number of personalized medicines is expected to fuel the growth of the bioprocess automation market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. Bioprocess automation helps personalized medicine by enabling precision and scalability in producing patient-specific drugs. For instance, according to Personalized Medicine Coalition, a US-based professional membership organization, in 2022, approving 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the increasing number of personalized medicines is driving the growth of the bioprocess automation market.
How is the bioprocess automation market segmented?
The bioprocess automation market covered in this report is segmented –
1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems
Subsegments:
1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report
Who are the top competitors in the bioprocess automation market?
Major companies operating in the bioprocess automation market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Corporation, Danaher Corporation, Amgen Inc., Merck KGaA, Parker-Hannifin Corporation, CSL Behring LLC, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf AG, Repligen Corporation, BIONET Research S.A., Flotek Industries Inc., Pierre Guerin SAS, Bioengineering AG, Genedata AG, ILS Automation, INFORS AG, Synthace Limited, Automated Control Concepts Inc., BlueSens gas sensor GmbH, DISTek Integration Inc., Securecell AG, Flownamics Analytical Instruments Inc., Inscripta Inc., PendoTECH Inc., Sartorius Stedim Biotech S.A.
Which key trends are expected to influence the bioprocess automation market in the coming years?
Major companies operating in the bioprocess automation market are developing innovative solutions, such as bioreactors to simplify bioprocessing operations. A bioreactor is an engineered system or device that provides an optimal and controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company that provides technologies and services that help advance and accelerate the development and manufacture of therapeutics, launched X-platform bioreactors to simplify single-use upstream bioprocessing operations. It is easy to operate, flexible, and more efficient in the process. It was first offered in 50 and 200 L capacities. They can increase process efficiency through ergonomic improvements, production capability, and simplified supply chain operations. The X-platform bioreactors can be used to manufacture cell and gene therapies as well as viral vectors, in addition to monoclonal antibodies (mAbs).
Which regional trends are influencing the bioprocess automation market, and which area dominates the industry?
North America was the largest region in the bioprocess automation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess automation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Bioprocess Automation Market Report 2025 Offer?
The bioprocess automation market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Bioprocess automation is using automated systems to monitor and control the bioprocessing workflow, which involves living cells, organisms, or components to produce biological products such as biopharmaceuticals. Biopharmaceutical businesses use bioprocess automation for better process control and optimization, higher product quality, decreased variability, increased throughput and efficiency, cost savings, and scalability.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14058
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
